Sign in to fuzzto save your conversations, follow your research and come back anytime.
Wockhardt
WOCKPHARMA
NSE
BSE
NSEBSESectorHealthcare
1,950.60
Loading chart…
In the news
Wockhardt targets Q1 2027 US launch for breakthrough antibiotic
Wockhardt posts ₹107 cr Q1 profit vs ₹108 cr loss last year
India's Pharma Renaissance: From Generics to Drug Discovery
Wockhardt's Zaynich becomes India's first FDA-approved antibiotic
Experts advise hold on IDFC First Bank, JSW Energy stocks
Wockhardt drops fifth straight session, down 0.67%
Wockhardt shares surge 2.19% for third straight session
Wockhardt targets 50% revenue from novel drugs within five years
Wockhardt's Zaynich becomes India's second US FDA-approved antibiotic
Wockhardt shares fall 8% after historic Zaynich approval rally
Sensex falls 293 pts; Nifty drops 57 pts amid broad selloff
Wockhardt shares hit record ₹2,420 after US FDA approves Zaynich antibiotic
Wockhardt's Zaynich: A Historic Breakthrough in Antibiotic Innovation
5 Low-Risk Pharma Stocks for 2026: Healthcare Screener Analysis
Wockhardt hits all-time high at ₹2,092 on CDSCO antibiotic approval
Wockhardt shares surge 8.35% for fifth straight session on US FDA approval
Wockhardt's Zaynich gets US FDA approval, first Indian NCE milestone
Wockhardt stock zooms 14% on historic US FDA approval for ZAYNICH
Ashok Leyland, Wipro, RIL lead stocks to watch today
Wockhardt shares surge 19% on strong Q4 results